Simon Lowry is the founder of Zenas BioPharma. Latest round: Series B. Backed by Enavate Sciences, Longitude Capital, Vivo Capital. Based in Waltham, MA.
Simon Lowry, M.D., was appointed as Chief Medical Officer of Zenas BioPharma in September 2022, where he leads the company's clinical development strategy for autoimmune disease therapies. He is associated with Zenas BioPharma's Series B financing of $118 million announced in late 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library